Close Menu

NEW YORK – Thermo Fisher Scientific and Milu Labs said today that they plan to collaborate to develop clinical diagnostic technologies for women's health in China.

Under a memorandum of understanding, the companies plan to explore opportunities to use Thermo Fisher's liquid chromatography-mass spectrometry instrumentation to develop tools to determine the risk for adverse pregnancy outcomes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.